Bayer shares surge 10% after major legal victory in Roundup cancer litigation: Time to buy?
Bayer AG saw its shares soar by 10% in early German trading following a crucial legal victory concerning its Roundup weedkiller. The surge came after a Philadelphia appeals court ruled in favor of Bayer’s Monsanto unit, overturning a previous decision that had found the company liable for cancer risks associated with the herbicide. This ruling […]
Full Article